BMPR1A Human

Bone Morphogenetic Protein Receptor Type IA Human Recombinant
Cat. No.
BT17258
Source
Insect Cells.
Synonyms

BMPR-1A, BMP-R1A, BMPR1A, BMR1A, CD292, CD-292, Serine/threonine-protein kinase receptor R5, SKR5, ALK-3, ACVRLK3, EC 2.7.11.30, CD292 antigen.

Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 90.0% as determined by
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

BMPR1A Human Recombinant extracellular domain produced in baculovirus is a monomeric, glycosylated, Polypeptide chain fused with 6xHis tag at C-terminus and having a molecular mass of 23 kDa.
The BMR1A is purified by proprietary chromatographic techniques.

Product Specs

Introduction

Bone morphogenetic protein (BMP) receptors are transmembrane serine/threonine kinases. This family includes type I receptors BMPR1A and BMPR1B, and the type II receptor BMPR2. These receptors are structurally similar to ACVR1 and ACVR2 receptors. Ligands for these receptors belong to the TGF-beta superfamily. TGF-betas initiate signal transduction by forming heteromeric complexes with two different types of serine/threonine kinase receptors: type I receptors (approximately 50-55 kDa) and type II receptors (approximately 70-80 kDa). Type II receptors can bind ligands independently of type I receptors. However, they require type I receptors for signaling. Conversely, type I receptors rely on type II receptors for ligand binding.

Description
Recombinant human BMPR1A extracellular domain is produced in baculovirus. It is a monomeric, glycosylated polypeptide chain with a C-terminal 6xHis tag. This protein has a molecular weight of 23 kDa.
BMR1A is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
CD292 was lyophilized from a sterile solution (1mg/ml) containing 1X PBS.
Solubility
Reconstitute the lyophilized ALK-3 in sterile PBS at a minimum concentration of 100 µg/ml. This solution can be further diluted with other aqueous solutions.
Stability
Lyophilized Bone Morphogenetic Protein Receptor 1A remains stable at room temperature for 3 weeks. However, it is recommended to store it desiccated below
-18°C. After reconstitution, store BMPR1A at 4°C for 2-7 days. For long-term storage, keep it at -18°C.
Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage.
Avoid repeated freeze-thaw cycles.
Purity
The purity is determined using the following methods:
(a) RP-HPLC analysis.
(b) SDS-PAGE analysis.
The purity is greater than 90.0%.
Biological Activity
The biological activity is evaluated by the ability to inhibit recombinant human BMP-2 induced alkaline phosphatase production in C2C12 myogenic cells. Typically, the ED50 for this effect is 1-3 µg/ml in the presence of 500 ng/ml recombinant human BMP-2, corresponding to a Specific Activity of 2,000 units/mg.
Synonyms

BMPR-1A, BMP-R1A, BMPR1A, BMR1A, CD292, CD-292, Serine/threonine-protein kinase receptor R5, SKR5, ALK-3, ACVRLK3, EC 2.7.11.30, CD292 antigen.

Source
Insect Cells.

Product Science Overview

Introduction

Bone Morphogenetic Protein Receptor Type IA (BMPR1A), also known as Activin Receptor-Like Kinase 3 (ALK3), is a crucial component of the transforming growth factor-beta (TGF-β) superfamily. This receptor is a transmembrane serine/threonine kinase that plays a significant role in various biological processes, including embryonic development, bone formation, and cellular differentiation .

Structure and Function

BMPR1A is a type I receptor that forms a heteromeric complex with type II receptors upon ligand binding. This complex is essential for the signal transduction of bone morphogenetic proteins (BMPs), which are key regulators of bone and cartilage development . The receptor’s structure includes an extracellular ligand-binding domain, a single transmembrane domain, and an intracellular serine/threonine kinase domain .

Biological Significance

BMPR1A is involved in numerous developmental processes. It is crucial for dorso-ventral patterning, neural crest development, and organogenesis, including the development of the heart, kidneys, and thymus . Additionally, BMPR1A plays a role in chondrogenesis, skeletal development, and hematopoiesis .

Recombinant BMPR1A

Recombinant BMPR1A is produced using recombinant DNA technology, which involves inserting the BMPR1A gene into an expression vector and introducing it into a host cell, such as E. coli or mammalian cells. The host cells then produce the BMPR1A protein, which can be purified and used for various research and therapeutic applications .

Applications

Recombinant BMPR1A is widely used in research to study BMP signaling pathways and their roles in development and disease. It is also utilized in therapeutic applications, such as tissue engineering and regenerative medicine, where it can promote bone and cartilage repair .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.